Abraxane, a novel Cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Annals of Oncology

• Publication date

  2006-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/ANNONC/MDL104PMID 16740598
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer.

  2005cited by this paper
• Randomized phase II/III trial of paclitaxel (P) plus carboplatin (C) with or without bevacizumab (NSC #704865) in patients with advanced non-squamous non-small cell lung cancer (NSCLC): An Eastern Cooperative Oncology Group (ECOG) Trial - E4599

  2005cited by this paper
• Comparative Preclinical and Clinical Pharmacokinetics of a Cremophor-Free, Nanoparticle Albumin-Bound Paclitaxel (ABI-007) and Paclitaxel Formulated in Cremophor (Taxol)

  2005cited by this paper
• Fatal outcome of a hypersensitivity reaction to paclitaxel: a critical review of premedication regimens

  2004cited by this paper
• Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342.

  2004cited by this paper
• Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy.

  2004cited by this paper
• Phase III trial of paclitaxel at two dose levels, the higher dose accompanied by filgrastim at two dose levels in platinum-pretreated epithelial ovarian cancer: an intergroup study.

  2003cited by this paper
• Quantitative analysis of albumin uptake and transport in the rat microvessel endothelial monolayer.

  2003cited by this paper
• SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system.

  2003cited by this paper
• Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel.

  2002cited by this paper
• Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.

  2002cited by this paper
• Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation.

  2001cited by this paper
• Assessment of neurotoxicity following repeated cremophor / ethanol injections in rats

  2001cited by this paper
• Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.

  2000cited by this paper
• Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancer.

  2000influential reference
• [New guidelines to evaluate the response to treatment in solid tumors].

  2000influential reference
• New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

  2000cited by this paper
• A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC).

  2000cited by this paper
• Cremophor EL-mediated alteration of paclitaxel distribution in human blood: clinical pharmacokinetic implications.

  1999influential reference
• Single-agent paclitaxel in the treatment of advanced non-small cell lung cancer.

  1999cited by this paper
• Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study.

  1998cited by this paper
• Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.

  1997cited by this paper
• Phase II trial of docetaxel in previously untreated advanced non-small-cell lung cancer: a Japanese cooperative study.

  1996cited by this paper
• Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.

  1994cited by this paper
• Hypersensitivity reactions from taxol.

  1990cited by this paper
• Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.

  1988cited by this paper
• Histamine release in dogs by Cremophor El® and its derivatives: Oxethylated oleic acid is the most effective constituent

  1977cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Engineering mesoporous silica nanoparticles for cancer immunotherapy: mechanistic insights, therapeutic synergies, and translational roadmap

  2026cites this paper
• Tumor-Targeted Delivery of an EGFR Inhibitor Prodrug via Site-Specific Albumin Conjugation.

  2026cites this paper
• Modernization of traditional Chinese medicine in cancer therapy: "3 D"innovative Chinese medicine.

  2026cites this paper
• Recent Trends in the Development and Clinical Translation of Polymer-based Targeted Therapeutic Nanoparticle

  2026cites this paper
• Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.0.

  2026cites this paper
• Emerging roles and mechanisms of nanoparticles in cancer treatment: innovations and horizons

  2026cites this paper
• Binding thermodynamics of ( E )-2-((2-hydroxybenzylidene)amino)-5-methylbenzonitrile and ( E )-2-((2-hydroxybenzylidene)amino)-5-methylbenzonitrile cobalt( ii ) with HSA: an experimental and molecular dynamic study

  2026cites this paper
• Biotechnology in materials science: A storied past and a bold future

  2025cites this paper
• Nanogold-albumin conjugates: transformative approaches for next-generation cancer therapy and diagnostics.

  2025cites this paper
• Amplifying therapeutic potential through optimization of bioavailability of poorly soluble flavonols via albumin-based nanoparticles

  2025cites this paper
• Self-Assembled Nanobody-Albumin Platform with Dye Encapsulation for NIR-II Imaging-Guided Photodynamic Therapy.

  2025cites this paper
• Nanoformulation-based drug delivery systems for the treatment of gastric cancer: recent developments and future prospects.

  2025cites this paper
• Ferroptosis-Enhanced Radiopharmaceutical Therapy via a Manganese-Based Nanoplatform.

  2025cites this paper
• Investigating the Application of Albumin-Bound Paclitaxel in the Treatment of Bladder Cancer and Its Potential Therapeutic Prospects

  2025cites this paper
• Macro-, micro- and nanoscale drug delivery systems in oncotherapy: current clinical status.

  2025cites this paper
• Precise nanoscale fabrication technologies, the “last mile” of medicinal development

  2025cites this paper
• A Universal Albumin Drugs-Cored Spherical Nucleic Acid (ad-SNA) Platform for Targeted Drug Delivery.

  2025cites this paper
• Transforming Medicine: Cutting-Edge Applications of Nanoscale Materials in Drug Delivery

  2025cites this paper
• “Nano-Paclitaxel” Unlocking Potential and Redefining Cancer Chemotherapy

  2025cites this paper
• Theranostic Near-Infrared Monoamine Oxidase Inhibitor (NMI) Protein Binding Interactions with MAOA and Albumin

  2025cites this paper
• Self-assembled redox sensitive mixed micelles of paclitaxel: Evaluation on 3D tumor spheroids, lung biodistribution, pharmacokinetics, optical and ultrasound/photoacoustic imaging for lung cancer therapy.

  2025cites this paper
• Preparation, Optimization, and Stability of Isosulfan Blue-Loaded Human Serum Albumin-Structured Nanocolloids

  2025cites this paper
• Hollow-core polydopamine nanocarriers for ultrasound-enhanced drug delivery

  2025cites this paper
• Advancement in Nanoparticle-Based Drug Delivery for Pulmonary Fibrosis: Current Insights and Future Prospects

  2025cites this paper
• Nanoformulations: Reforming treatment for non-small cell lung cancer metastasis.

  2025cites this paper
• Nanofibers for paclitaxel delivery: A promising avenue for cancer therapy.

  2025cites this paper
• Copper peroxide incorporated BSA-NPs: a pH-responsive, self-supplying source of reactive oxygen species for cancer cell destruction via polarization of macrophages to the M1 phenotype.

  2025cites this paper
• Current Developments of Iron Oxide Nanomaterials as MRI Theranostic Agents for Pancreatic Cancer

  2025cites this paper
• Dual acting oxaliplatin (IV) prodrug loaded albumin nanoparticles for safer synergistic anticancer action against triple negative breast cancer

  2025cites this paper
• ECM, integrins, and DDRs: A nexus of cancer progression, therapy, and future directions.

  2025cites this paper
• Binding Thermodynamics of 1,3-bis(((E-1H-pyrrol-2-yl) methylene) amino) propan-2-ol palladium(II) with HSA and Its Intercalative Behaviour in ctDNA

  2025cites this paper
• Recent advances in cancer nanomedicine: From smart targeting to personalized therapeutics - pioneering a new era in precision oncology

  2025cites this paper
• Fabrication and Evaluation of Hyaluronic Acid Coated Albumin Nanoparticles for Delivery of Gemcitabine.

  2025cites this paper
• Localised drug delivery for the treatment of cervical cancer

  2025cites this paper
• Engineered dual-functional gold nanoparticles enhance radiosensitization in prostate cancer cells: synergistic action of curcumin and gold

  2025cites this paper
• Advances in targeted therapy for tumor with nanocarriers: A review

  2025cites this paper
• Nano-enabled strategies for targeted immunotherapy in gastrointestinal cancers

  2025cites this paper
• Advances in paclitaxel nanoformulations: A systematic review of in vivo therapeutic efficacy and safety enhancements.

  2025cites this paper
• Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges

  2025cites this paper
• Concurrent and consolidative carboplatin plus nab-paclitaxel or paclitaxel in locally advanced NSCLC A multicenter, randomized clinical trial.

  2025cites this paper
• Polymeric Micellar Paclitaxel Plus Cisplatin Combined With Tislelizumab as the First‐Line Treatment of Advanced Unresectable Esophageal Squamous Cell Carcinoma: A Phase II Study

  2025influential citation
• Nanosuspension Innovations: Expanding Horizons in Drug Delivery Techniques

  2025cites this paper
• Selenium Nanoparticles in Critical Illness—Anti-Inflammatory and Antioxidant Effects

  2025cites this paper
• Preparation and evaluation of Baicalin-loaded albumin nanoparticles for anti-breast cancer activity.

  2025cites this paper
• Advances in Anthocyanin Nanoparticle Delivery Systems in Anti-Inflammatory Therapies.

  2025cites this paper
• A fatty acid modification strategy to improve the binding affinity of Epirubicin to human serum albumin for efficient cancer therapy

  2025cites this paper
• Albumin Encapsulation of Cyanine Dye for High-Performance NIR-II Imaging-Guided Photodynamic Therapy

  2025cites this paper
• Development of Deferoxamine‐Functionalized Cyclodextrin Polymer for Targeted Iron Chelation

  2025cites this paper
• Chemical Insights into Oligonucleotide-Protein Binding for Therapeutic Applications.

  2025cites this paper
• Upcoming generation nanoengineered antimicrobial delivery system for targeting multidrug-resistant microbes

  2025cites this paper
• Navigating the Future: Advancements in Monoclonal Antibody Nanoparticle Therapy for Cancer

  2024cites this paper
• Critical Role of Nanomaterial Mechanical Properties in Drug Delivery, Nanovaccines and Beyond

  2024cites this paper
• Recent nanoengineered therapeutic advancements in sepsis management

  2024cites this paper
• Nanomedicine in cancer treatment - an overview

  2024cites this paper
• Developing a novel P-glycoprotein inhibitor and pairing it with oral paclitaxel liposomes for enhanced cancer therapy.

  2024cites this paper
• Two Strategies of Enhancing the Therapeutic Potential of a Coumarin Probe: Integration of a Protonatable Moiety and BSA-Based Nanoparticle Formation

  2024cites this paper
• Advances in Drug Delivery Systems for Lipophilic Drug Paclitaxel: Developments, Challenges, and Opportunities (A Review)

  2024cites this paper
• Sintilimab Combined with Nanoparticle Albumin-Bound Paclitaxel-Based Chemotherapy in Severe Locally Advanced or Metastatic Squamous NSCLC Showed Good Efficacy and Safety: A Pilot Retrospective Analysis

  2024cites this paper
• A Novel Self-Assembled Paclitaxel Nanodispersion Facilitates Rapid In-Vitro/In-Vivo Dissociation and Protein Binding

  2024cites this paper
• Human Serum Albumin‐Coated 10B Enriched Carbon Dots as Targeted “Pilot Light” for Boron Neutron Capture Therapy

  2024cites this paper
• Chemical conjugation mitigates immunotoxicity of chemotherapy via reducing receptor-mediated drug leakage from lipid nanoparticles

  2024cites this paper
• Revolutionizing Cancer Treatment: Harnessing the Power of Mesenchymal Stem Cells for Precise Targeted Therapy in the Tumor Microenvironment.

  2024cites this paper
• Drug Delivery Systems for Natural Medicines in Cancer Therapy.

  2024cites this paper
• Prodrug-inspired therapeutics: albuminized ceria nanozymes for osteoarthritis treatment

  2024cites this paper
• Engineering Biomimetic Protein Camouflage for Delivering Peptide/siRNA Nanocomplexes.

  2024cites this paper
• Emerging Targets and Therapeutics in Immuno-Oncology: Insights from Landscape Analysis

  2024cites this paper
• Extracellular vesicles for breast cancer diagnosis and therapy

  2024cites this paper
• A Library of Custom PEG-Lipids reveals a Double-PEG-Lipid with Drastically Enhanced Paclitaxel Solubility and Human Cancer Cell Cytotoxicity when used in Fluid Micellar Nanoparticles

  2024cites this paper
• Quality by design empowered preparation of itraconazole albumin nanoparticles for prostate cancer

  2024cites this paper
• Camrelizumab combined with apatinib and nanoparticle albumin-bound paclitaxel in lung adenocarcinoma (CAPAP-lung): a single-arm phase II study

  2024cites this paper
• Application of Nanotechnology in Cancer Therapy: Potential and Limitations

  2024cites this paper
• Click reaction-induced in situ nanoparticle aggregation for cancer imaging and treatment

  2024cites this paper
• Direct Assembly of Bioactive Nanoparticles Constructed from Polyphenol-Nanoengineered Albumin.

  2024cites this paper
• Evaluation the Injectability of Injectable Microparticle Delivery Systems on the Basis of Injection Force and Discharged Rate.

  2023cites this paper
• PLGA: A Wow Smart Biodegradable Polymer in Drug Delivery System

  2023cites this paper
• One-pot preparation of mannan-coated antigen nanoparticles using human serum albumin as a matrix for tolerance induction.

  2023cites this paper
• Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens

  2023cites this paper
• Perspectives for Improving the Tumor Targeting of Nanomedicine via the EPR Effect in Clinical Tumors

  2023cites this paper
• Targeting endothelial permeability in the EPR effect.

  2023cites this paper
• Drug delivery breakthrough technologies - A perspective on clinical and societal impact.

  2023cites this paper
• Nanotechnology Approaches for Prevention and Treatment of Chemotherapy-Induced Neurotoxicity, Neuropathy, and Cardiomyopathy in Breast and Ovarian Cancer Survivors.

  2023cites this paper
• Propensities of Fatty Acid-Modified ASOs: Self-Assembly vs Albumin Binding.

  2023cites this paper
• Nanoscale drug delivery systems for cancer therapy using paclitaxel— A review of challenges and latest progressions

  2023cites this paper
• Facile preparation of cabazitaxel-loaded nanoparticles directly lyophilized from dioxane

  2023cites this paper
• Theranostic applications of selenium nanomedicines against lung cancer

  2023cites this paper
• Integration of TADF Photosensitizer as "Electron Pump" and BSA as "Electron Reservoir" for Boosting Type I Photodynamic Therapy.

  2023cites this paper
• Phase I study of cisplatin and nanoparticle albumin‐bound‐paclitaxel combined with concurrent radiotherapy in locally advanced esophageal squamous cell carcinoma

  2023cites this paper
• Targeted Delivery of Anticancer Therapeutics with Polymers by Harnessing Tumor Microenvironment Acidity

  2023cites this paper
• HDACIs and TKIs combinations and their liposomal delivery for cancer treatment.

  2023cites this paper
• Treg-targeted efficient-inducible platform for collagen-induced arthritis treatment

  2023cites this paper
• Oxocarbon Acids and their Derivatives in Biological and Medicinal Chemistry.

  2023cites this paper
• Artificial Intelligence Aids in Development of Nanomedicines for Cancer Management.

  2023cites this paper
• Functionalized Carbon Nanoparticles as Theranostic Agents and Their Future Clinical Utility in Oncology

  2023cites this paper
• Targeted Fusogenic Liposomes for Effective Tumor Delivery and Penetration of Lipophilic Cargoes.

  2023cites this paper
• Advanced Nanomaterials in Medical 3D Printing

  2023cites this paper
• Artificial Intelligence Applications for Biomedical Cancer Research: A Review

  2023cites this paper
• Nanomedicine Combats Drug Resistance in Lung Cancer

  2023cites this paper
• Unlocking the synthetic approaches and clinical application of approved small-molecule drugs for gastrointestinal cancer treatment: A comprehensive exploration.

  2023cites this paper
• Inorganic Nanoparticles as Radiosensitizers for Cancer Treatment

  2023cites this paper
• Nanomaterials for detection of biomolecules and delivering therapeutic agents in theragnosis: A review.

  2023cites this paper